Searchable abstracts of presentations at key conferences in endocrinology

ea0020p156 | Thyroid | ECE2009

Analysis of ghrelin and obestatin levels in children with thyroid disease

Bossowski Artur , Sawicka Beata , Szalecki Mieczyslaw , Urban Miroslawa , Rogowski Franciszek , Koput Alicja , Zelazowska-Rutkowska Beata , Tobolczyk Jolanta

Thyroid disease let to change of weight – in hyperthyroid body mass is reduced, but in hypothyroid it is increased. Recently researches suggest that many new bioactive substances, like ghrelin and obestatin, play a role in regulation of body mass. These closely related hormones have paradoxically different effects- ghrelin increases, but obestatin decreases appetite. The aim of the study was to evaluate ghrelin and obestatin levels in young patients with untreated Graves&...

ea0035p952 | Steroid metabolism and action | ECE2014

A hypercoagulable state associated with intravenous pulse methylprednisolone (MP) therapy in patients with Graves' orbitopathy

Rutkowska Beata , Miskiewicz Piotr , Trautsolt-Jeziorska Katarzyna , Pirko-Kotela Katarzyna , Milczarek-Banach Justyna , Wolczanska Natalia , Jelenska Magdalena , Glowczynska Renata , Bednarczuk Tomasz

Introduction: Chronic exposure to glucocorticoid excess, either endogenous or exogenous, is associated with a hypercoagulable state and a high thromboembolism risk. The underlying mechanism of this phenomenon is still unclear. Clinical studies have indicated various abnormalities of procoagulant, anti-coagulant and fibrynolytic factors, e.g.: alterations of clotting factors (F), plasminogen activator inhibitor (PAI-1), plasminogen, antithrombin. Moreover, other consequences of...